Ray Dalio's ACAD Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 163.2K shares of ACADIA Pharmaceuticals Inc. (ACAD) worth $3.48 M, representing 0.01% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in ACAD, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 152.3K shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's ACADIA Pharmaceuticals (ACAD) Holding Value Over Time
Track share changes against reported price movement
Quarterly ACADIA Pharmaceuticals (ACAD) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2022 | +8,989 | New Buy | 8,989 | $24.25 |
| Q2 2022 | +1,929 | Add 21.46% | 10,918 | $14.11 |
| Q3 2022 | -10,918 | Sold Out | 10,918 | $0.00 |
| Q3 2025 | +163,245 | New Buy | 163,245 | $21.34 |
Ray Dalio's ACADIA Pharmaceuticals Investment FAQs
Ray Dalio first purchased ACADIA Pharmaceuticals Inc. (ACAD) in Q1 2022, acquiring 8,989 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held ACADIA Pharmaceuticals Inc. (ACAD) for 15 quarters since Q1 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to ACADIA Pharmaceuticals Inc. (ACAD) was in Q3 2025, adding 163,245 shares worth $3.48 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 163,245 shares of ACADIA Pharmaceuticals Inc. (ACAD), valued at approximately $3.48 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ACADIA Pharmaceuticals Inc. (ACAD) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in ACADIA Pharmaceuticals Inc. (ACAD) was 163,245 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.